• 1
    Cooper DK, Good AH, Koren E et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1: 198205.
  • 2
    Schmoeckel M, Nollert G, Shahmohammadi M et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 1996; 62: 729734.DOI: 10.1097/00007890-199609270-00005
  • 3
    Kolber-Simonds D, Lai L, Watt SR et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101: 73357340.DOI: 10.1073/pnas.0307819101
  • 4
    Itescu S, Artrip JH, Kwiatkowski PA et al. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products. Ann Transplant 1997; 2: 1420.
  • 5
    Itescu S, Kwiatkowski P, Wang SF et al. Circulating human mononuclear cells exhibit augmented lysis of pig endothelium after activation with interleukin 2. Transplantation 1996; 62: 19271933.DOI: 10.1097/00007890-199612270-00043
  • 6
    Watier H, Guillaumin JM, Vallee I et al. Human NK cell-mediated direct and IgG-dependent cytotoxicity against xenogeneic porcine endothelial cells. Transpl Immunol 1996; 4: 293299.DOI: 10.1016/S0966-3274(96)80050-5
  • 7
    Birmele B, Thibault G, Watier H et al. Human peripheral blood lymphocyte adhesion to xenogeneic porcine aortic endothelial cells: preferential adhesion of CD3-CD16+ NK cells. Transplant Proc 1994; 26: 11501151.
  • 8
    Birmele B, Thibault G, Nivet H, Gruel Y, Bardos P, Lebranchu Y. Human lymphocyte adhesion to xenogeneic porcine endothelial cells: modulation by human TNF-alpha and involvement of VLA-4 and LFA-1. Transpl Immunol 1996; 4: 265270.
  • 9
    Quan D, Bravery C, Chavez G, Richards A, Cruz G, Copeman L et al. Identification, detection, and in vitro characterization of cynomolgus monkey natural killer cells in delayed xenograft rejection of hDAF transgenic porcine renal xenografts. Transplant Proc 2000; 32: 936937.DOI: 10.1016/S0041-1345(00)01046-0
  • 10
    Seebach JD, Yamada K, McMorrow IM, Sachs DH, DerSimonian H. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996; 3: 188197.
  • 11
    Gourlay WA, Chambers WH, Monaco AP, Maki T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998; 65: 727734.DOI: 10.1097/00007890-199803150-00021
  • 12
    Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 56585667.
  • 13
    Bach FH, Stuhlmeier KM, Vanhove B et al. Endothelial cells in xenotransplantation: do they accommodate? Transplant Proc 1994; 26: 11671169.
  • 14
    Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992; 149: 14161423.
  • 15
    Le Hir M, Kaissling B. Distribution and regulation of renal ecto-5′-nucleotidase: implications for physiological functions of adenosine. Am J Physiol 1993; 264(3 Pt 2): F377F387.
  • 16
    Schrader J, Baumann G, Gerlach E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch 1977; 372: 2935.DOI: 10.1007/BF00582203
  • 17
    Lennon PF, Taylor CT, Stahl GL, Colgan SP. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 1998; 188: 14331443.DOI: 10.1084/jem.188.8.1433
  • 18
    Mills DCB, MacFarlane DE, Lemmex BWG, Haslam RJ. Receptors for nucleosides and nucleotides on blood platelets. In: BerneRM, RallTW, RubioR, eds. Regulatory functions of adenosine. The Hague/Boston/London : Nijhof Publs, 1983: 277289.
  • 19
    Parmely MJ, Zhou WW, Edwards CK III, Borcherding DR, Silverstein R, Morrison DC. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 1993; 151: 389396.
  • 20
    Lappin D, Whaley K. Adenosine A2 receptors on human monocytes modulate C2 production. Clin Exp Immunol 1984; 57: 454460.
  • 21
    Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983; 158: 11601177.
  • 22
    Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. J Immunol 1999; 162: 73767382.
  • 23
    Williams BA, Manzer A, Blay J, Hoskin DW. Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells. Biochem Biophys Res Commun 1997; 231: 264269.DOI: 10.1006/bbrc.1997.6077
  • 24
    Thompson LF, Ruedi JM, Glass A et al. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 1990; 35: 919.
  • 25
    Christensen LD, Andersen V. Natural killer cells lack ecto-5′-nucleotidase. Nat Immun 1992; 11: 16.
  • 26
    Imai M, Takigami K, Guckelberger O et al. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 2000; 70: 864870.DOI: 10.1097/00007890-200009270-00003
  • 27
    Smolenski RT, Kochan Z, Karbowska J et al. Low expression of ecto-5′-nucleotidase in the pig heart – a potential barrier to xenotransplantation. J Heart Lung Transplant 2001; 20: 214215.DOI: 10.1016/S1053-2498(00)00467-8
  • 28
    Smolenski RT, Kochan Z, McDouall R, Page C, Seymour AML, Yacoub MH. Endothelial nucleotide catabolism and adenosine production. Cardiovasc Res 1994; 28: 100104.
  • 29
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248254.
  • 30
    Kochan Z, Smolenski RT, Yacoub MH, Seymour AML. Nucleotide and adenosine metabolism in different cell types in human and rat heart. J Mol Cell Cardiol 1994; 26: 14971503.DOI: 10.1006/jmcc.1994.1168
  • 31
    Resta R, Hooker SW, Hansen KR et al. Murine ecto-5′-nucleotidase (CD73): cDNA cloning and tissue distribution. Gene 1993; 133: 171177.DOI: 10.1016/0378-1119(93)90635-G
  • 32
    Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002; 22: 364373.
  • 33
    Koyamada N, Miyatake T, Candinas D et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 1996; 62: 17391743.DOI: 10.1097/00007890-199612270-00008
  • 34
    Luthje J. Origin, metabolism and function of extracellular adenine nucleotides in the blood [published erratum appears in Klin Wochenschr 1989 May 15;67(10):558]. Klin Wochenschr 1989; 67: 317327.
  • 35
    Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 1997; 79: 210.
  • 36
    Yegutkin GG, Henttinen T, Samburski SS, Spychala J, Jalkanen S. The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. Biochem J 2002; 367(Pt 1): 121128.DOI: 10.1042/BJ20020439
  • 37
    Dombrowski KE, Cone JC, Bjorndahl JM, Phillips CA. Irreversible inhibition of human natural killer cell natural cytotoxicity by modification of the extracellular membrane by the adenine nucleotide analog 5′-p-(fluorosulfonyl)benzoyl adenosine. Cell Immunol 1995; 160: 199204.DOI: 10.1016/0008-8749(95)80028-H
  • 38
    Apasov SG, Koshiba M, Chused TM, Sitkovsky MV. Effects of extracellular ATP and adenosine on different thymocyte subsets: possible role of ATP-gated channels and G protein-coupled purinergic receptor. J Immunol 1997; 158: 50955105.
  • 39
    Priebe T, Platsoucas CD, Nelson JA. Adenosine receptors and modulation of natural killer cell activity by purine nucleosides. Cancer Res 1990; 50: 43284331.
  • 40
    MacKenzie WM, Hoskin DW, Blay J. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. Cancer Res 1994; 54: 35213526.
  • 41
    Harish A, Hohana G, Fishman P, Arnon O, Bar-Yehuda S. A3 adenosine receptor agonist potentiates natural killer cell activity. Int J Oncol 2003; 23: 12451249.
  • 42
    Hanson RD, Grisolano JL, Ley TJ. Consensus AP-1 and CRE motifs upstream from the human cytotoxic serine protease B (CSP-B/CGL-1) gene synergize to activate transcription. Blood 1993; 82: 27492757.
  • 43
    Ullberg M, Jondal M, Lanefelt F, Fredholm BB. Inhibition of human NK cell cytotoxicity by induction of cyclic AMP depends on impaired target cell recognition. Scand J Immunol 1983; 17: 365373.
  • 44
    Whalen MM, Bankhurst AD. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem J 1990; 272: 327331.
  • 45
    Bancu AC, Gherman M, Sulica A, Goto T, Farrar W, Herberman RB. Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity. Cell Immunol 1988; 114: 246256.
  • 46
    Haslam RJ, Cusack NJ. Blood platelet receptors for adenylate cyclase. In: BurnstockG, ed. Purinergic receptors. London : Chapman and Hall, 1981: 221286.
  • 47
    Zhao ZQ, Budde JM, Morris C et al. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol 2001; 33: 5768.DOI: 10.1006/jmcc.2000.1275
  • 48
    Ikeda U, Kurosaki K, Shimpo M, Okada K, Saito T, Shimada K. Adenosine stimulates nitric oxide synthesis in rat cardiac myocytes. Am J Physiol 1997; 273(1 Pt 2): H59H65.